{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T22:29:14Z","timestamp":1773786554548,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI-071118"],"award-info":[{"award-number":["R01 AI-071118"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 AI114762"],"award-info":[{"award-number":["R21 AI114762"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Valley Fever of the Americas Foundation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.vaccine.2016.08.078","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T17:36:30Z","timestamp":1473788190000},"page":"5336-5343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii"],"prefix":"10.1016","volume":"34","author":[{"given":"Brady J.","family":"Hurtgen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Castro-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria del Pilar","family":"Jim\u00e9nez-Alzate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garry T.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiung-Yu","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.08.078_b0005","first-page":"185","article-title":"Coccidioidomycosis: epidemiology","volume":"5","author":"Brown","year":"2013","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2016.08.078_b0010","doi-asserted-by":"crossref","first-page":"e0136753","DOI":"10.1371\/journal.pone.0136753","article-title":"The changing epidemiology of coccidioidomycosis in Los Angeles (LA) County, California, 1973\u20132011","volume":"10","author":"Guevara","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.08.078_b0015","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.mib.2012.05.017","article-title":"Immunology of fungal infections: lessons learned from animal models","volume":"15","author":"Steele","year":"2012","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.vaccine.2016.08.078_b0020","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1196\/annals.1406.029","article-title":"Experimental animal models of coccidioidomycosis","volume":"1111","author":"Clemons","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2016.08.078_b0025","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/13693780410001687349","article-title":"A vaccine against coccidioidomycosis is justified and attainable","volume":"42","author":"Cole","year":"2004","journal-title":"Med Mycol"},{"key":"10.1016\/j.vaccine.2016.08.078_b0030","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1128\/CMR.17.4.804-839.2004","article-title":"Coccidioidomycosis: host response and vaccine development","volume":"17","author":"Cox","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2016.08.078_b0035","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1128\/IAI.05726-11","article-title":"Vaccine immunity to coccidioidomycosis occurs by early activation of three signal pathways of T helper cell response (Th1, Th2, and Th17)","volume":"79","author":"Hung","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.08.078_b0040","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1172\/JCI43984","article-title":"Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice","volume":"121","author":"Wuthrich","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2016.08.078_b0045","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1086\/516115","article-title":"Prediction of relapse after treatment of coccidioidomycosis","volume":"25","author":"Oldfield","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.08.078_b0050","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/00007890-199710150-00014","article-title":"HLA gene and haplotype frequencies in the North American population: the National Marrow Donor Program Donor Registry","volume":"64","author":"Mori","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.vaccine.2016.08.078_b0055","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.4049\/jimmunol.160.7.3363","article-title":"Several common HLA-DR types share largely overlapping peptide binding repertoires","volume":"160","author":"Southwood","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.08.078_b0060","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1128\/IAI.00961-06","article-title":"Multivalent recombinant protein vaccine against coccidioidomycosis","volume":"74","author":"Tarcha","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.08.078_b0065","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1128\/IAI.00459-09","article-title":"A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB\/c mice against coccidioidomycosis","volume":"77","author":"Xue","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.08.078_b0070","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1084\/jem.183.6.2635","article-title":"HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis","volume":"183","author":"Ito","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.08.078_b0075","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/15525","article-title":"A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor","volume":"23","author":"Madsen","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2016.08.078_b0080","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1016\/j.vaccine.2005.01.147","article-title":"Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection","volume":"23","author":"Xue","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.078_b0085","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1128\/IAI.66.5.2342-2345.1998","article-title":"Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules","volume":"66","author":"Zimmermann","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.08.078_b0090","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1016\/j.vaccine.2012.04.084","article-title":"An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection","volume":"30","author":"Hung","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.078_b0095","first-page":"1039","article-title":"In vitro whole-blood analysis of cellular immunity in patients with active coccidioidomycosis by using the antigen preparation T27K","volume":"9","author":"Ampel","year":"2002","journal-title":"Clin Diag Lab Immunol"},{"key":"10.1016\/j.vaccine.2016.08.078_b0100","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/art.30445","article-title":"Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1\u22170401-positive humanized mice and rheumatoid arthritis patients","volume":"63","author":"Snir","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.vaccine.2016.08.078_b0105","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.4049\/jimmunol.164.7.3535","article-title":"Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice","volume":"164","author":"Touloukian","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.08.078_b0110","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1128\/IAI.74.1.516-527.2006","article-title":"A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice","volume":"74","author":"Tarcha","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.08.078_b0115","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13072-015-0047-z","article-title":"Genetic and epigenetic variation among inbred mouse littermates: identification of inter-individual differentially methylated regions","volume":"8","author":"Oey","year":"2015","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.vaccine.2016.08.078_b0120","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/nar\/gkv014","article-title":"Development of a unique epigenetic signature during in vivo Th17 differentiation","volume":"43","author":"Yang","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2016.08.078_b0125","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1128\/IAI.00566-12","article-title":"Construction and evaluation of a novel recombinant T cell epitope-based vaccine against coccidioidomycosis","volume":"80","author":"Hurtgen","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.08.078_b0130","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1128\/IAI.67.6.2935-2940.1999","article-title":"Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen","volume":"67","author":"Abuodeh","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.08.078_b0135","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1128\/AAC.46.8.2420-2426.2002","article-title":"Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits","volume":"46","author":"Clemons","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2016.08.078_b0140","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1086\/375235","article-title":"Successful treatment of coccidioidal meningitis with voriconazole","volume":"36","author":"Cortez","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.08.078_b0145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7205\/MILMED.169.2.157","article-title":"A 22-year-old Army private with chest pain and weight loss","volume":"169","author":"Gibbs","year":"2004","journal-title":"Mil Med"},{"key":"10.1016\/j.vaccine.2016.08.078_b0150","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2334-6-26","article-title":"Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole","volume":"6","author":"Park","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2016.08.078_b0155","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1128\/IAI.01148-13","article-title":"Vaccinated C57BL\/6 mice develop protective and memory T cell responses to Coccidioides posadasii infection in the absence of interleukin-10","volume":"82","author":"Hung","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.08.078_b0160","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1128\/IAI.01579-13","article-title":"Interleukin-1 receptor but not Toll-Like receptor 2 is essential for MyD88-dependent Th17 immunity to Coccidioides infection","volume":"82","author":"Hung","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.08.078_b0165","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.4049\/jimmunol.1302314","article-title":"C-type lectin receptors differentially induce Th17 cells and vaccine immunity to the endemic mycosis of North America","volume":"192","author":"Wang","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.08.078_b0170","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-0-387-09550-9_11","article-title":"The damage-response framework of microbial pathogenesis and infectious diseases","volume":"635","author":"Pirofski","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2016.08.078_b0175","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nri3874","article-title":"Synchronizing transcriptional control of T cell metabolism and function","volume":"15","author":"Man","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2016.08.078_b0180","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/1471-2180-12-218","article-title":"Factors regulated by interferon gamma and hypoxia-inducible factor 1A contribute to responses that protect mice from Coccidioides immitis infection","volume":"12","author":"Woelk","year":"2012","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.vaccine.2016.08.078_b0185","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev.iy.11.040193.001555","article-title":"T cell-dependent B cell activation","volume":"11","author":"Parker","year":"1993","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2016.08.078_b0190","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1146\/annurev.iy.13.040195.003255","article-title":"T cell-independent antigens type 2","volume":"13","author":"Mond","year":"1995","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2016.08.078_b0195","doi-asserted-by":"crossref","first-page":"14292","DOI":"10.1073\/pnas.1009234107","article-title":"Proinflammatory T helper type 17 cells are effective B-cell helpers","volume":"107","author":"Mitsdoerffer","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2016.08.078_b0200","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/CMR.3.3.247","article-title":"Serology of coccidioidomycosis","volume":"3","author":"Pappagianis","year":"1990","journal-title":"Clin Microbiol Rev"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1630785X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1630785X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T02:48:22Z","timestamp":1692499702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1630785X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":40,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0264410X1630785X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.078","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}